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RESEARCH ARTICLE
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Abstract
Introduction
Puerperal sepsis causes 10% of maternal deaths in Africa, but prospective studies on inci-
dence, microbiology and antimicrobial resistance are lacking.
Methods
We performed a prospective cohort study of 4,231 Ugandan women presenting to a regional
referral hospital for delivery or postpartum care, measured vital signs after delivery, per-
formed structured physical exam, symptom questionnaire, and microbiologic evaluation of
febrile and hypothermic women. Malaria rapid diagnostic testing, blood and urine cultures
were performed aseptically and processed at Epicentre Mbarara Research Centre. Antimi-
crobial susceptibility and breakpoints were determined using disk diffusion per EUCAST
standards. Hospital diagnoses, treatments and outcomes were abstracted from patient
charts.
Results
Mean age was 25 years, 12% were HIV-infected, and 50% had cesarean deliveries. Approx-
imately 5% (205/4176) with1 temperature measurement recorded developed postpartum
fever or hypothermia; blood and urine samples were collected from 174 (85%), and 17 oth-
ers were evaluated clinically. Eighty-four (48%) had at least one confirmed source of infec-
tion: 39% (76/193) clinical postpartum endometritis, 14% (25/174) urinary tract infection
(UTI), 3% (5/174) bloodstream infection. Another 3% (5/174) had malaria. Overall, 30/174
(17%) had positive blood or urine cultures, and Acinetobacter species were the most
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common bacteria isolated. Of 25 Gram-negatives isolated, 20 (80%) were multidrug-resis-
tant and cefepime non-susceptible.
Conclusions
For women in rural Uganda with postpartum fever, we found a high rate of antibiotic resis-
tance among cultured urinary and bloodstream infections, including cephalosporin-resistant
Acinetobacter species. Increasing availability of microbiology testing to inform appropriate
antibiotic use, development of antimicrobial stewardship programs, and strengthening infec-
tion control practices should be high priorities.
Introduction
The World Health Organization (WHO) estimates puerperal sepsis causes 10% of maternal
deaths in Africa.[1] However, prospective studies of pregnancy-related infections are scant,
and most data come from retrospective studies of maternal deaths without formal microbio-
logical investigation or antimicrobial susceptibility testing.[2–6] Postpartum infections are
pregnancy-related infections occurring between the onset of rupture of membranes in labor
and the 42nd day after delivery, and are important causes of morbidity and mortality world-
wide. The most common postpartum infections include endometritis (puerperal sepsis), uri-
nary tract infections (UTIs), bloodstream infections, and cesarean surgical site infections.[3, 5,
7] Cesarean delivery is considered the single most important risk factor for postpartum infec-
tion due to skin and uterine disruption, bladder catheterization, and healthcare system contact,
though peri-procedural antibiotic prophylaxis reduces the risk significantly.[3, 8]
To date, most research on postpartum infection has occurred in high-resource settings. In
low-resource settings, differences in antibiotic prophylaxis and treatment, cesarean delivery
practices, human immunodeficiency virus (HIV) prevalence, access to microbiology testing,
antimicrobial stewardship and infection control practices may lead to differences in infection
incidence, microbiology, and antimicrobial resistance.[4, 5, 9, 10] To address this gap in knowl-
edge, we performed a prospective cohort study of women presenting to a Ugandan regional
referral hospital for delivery or care within the 42-day postpartum period. We sought to better
define the incidence, microbiology, and antimicrobial resistance of postpartum infections in
this resource-limited setting to guide antibiotic selection, urinary catheter use, and antimicro-
bial stewardship.
Methods
Study site
Participants were recruited from Mbarara Regional Referral Hospital (MRRH) in Mbarara,
Uganda between March and October, 2015. MRRH is an approximately 300-bed academic
hospital affiliated with Mbarara University of Science and Technology (MUST). It is the largest
teaching and referral hospital for Western Uganda, with population of nine million people liv-
ing in a predominantly rural, agrarian setting. According to local standard of care, women
hospitalized for delivery and postpartum care undergo daily and as-needed vital signs moni-
toring. Vaginal deliveries are attended by midwives, while cesarean deliveries are conducted
by obstetricians. Current hospital policy is for women delivering by cesarean to receive a single
dose of peri-procedural antibiotic prophylaxis (ampicillin or ceftriaxone), usually given within
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30 minutes of skin incision. In addition, after cesarean delivery women are treated with combi-
nation intravenous ceftriaxone and metronidazole for three days, followed by five days of oral
cefixime. Antibiotics are not routinely given to women delivering vaginally. Microbiological
evaluation of potential infections is not routine, but when requested, samples are processed at
MUST’s teaching lab adjacent to MRRH. There, bacterial identification is performed using tra-
ditional biochemical methods with limited supplies.
Participant recruitment and clinical data collection
All women presenting to MRRH maternity ward in labor for delivery or for care within 42 days
postpartum were approached for enrollment, including women hospitalized for antenatal care
who subsequently labored. All study participants provided written informed consent. Potential
participants were excluded if they did not speak English or Runyankole, if they declined consent,
or were incapacitated and next-of-kin declined surrogate consent. Enrolled women were followed
by a team of trained research nurses measuring vital signs including oral temperature approxi-
mately every eight hours after delivery for the duration of the participant’s hospitalization.
Sample collection, microbiology and antimicrobial susceptibility testing
Participants with fever >38.0˚C or hypothermia < 36.0˚C were tested for malaria using SD
Bioline Malaria Ag Pf/Pan rapid diagnostic test (Standard Diagnostics, Gyeonggi, Korea),
provided a clean-catch urine sample, and had peripheral blood drawn aseptically into Bec-
ton Dickinson (BD) BACTEC (Becton, Dickinson and Company, Franklin Lakes, USA) bot-
tles. Two aerobic, two anaerobic and one mycobacterial blood culture were transported to
the Epicentre Mbarara Research Centre microbiology laboratory adjacent to MRRH. Epi-
centre complies with Good Clinical Laboratory Practice standards, is seeking accreditation
with Strengthening Laboratory Management Toward Accreditation (SLMTA), and is over-
seen by Epicentre France, whose staff perform regular on-site quality control and training.
On arrival to Epicentre, blood culture bottles were incubated in a BD BACTEC 9240 auto-
mated blood culture system for seven days before reporting no growth. Mycobacterial cul-
tures were reported negative after 42 days’ incubation. When the BACTEC system detected
growth, Gram stain and sub-culture were performed, using enriched and selective media
for subculture. Urine samples were obtained after participants self-cleansed the perineum
with castile soap towlettes (for non-catheterized participants) or through nurse-collected
aspirate of 10mL urine from externally-cleansed catheter tubing (for catheterized partici-
pants). Urine was transported to Epicentre in sterile collection containers and refrigerated
at 2–8˚C for not more than 12 hours. Urinalysis was performed using Wellkang (London,
England) commercial test strips. After macroscopic and microscopic examination, urine
was incubated on CHROMagar Orientation medium (CHROMagar, Paris, France) and
incubated at 37˚C until growth was observed or three days, whichever came first. If three or
fewer colony types were isolated, Gram stain, subculture, colony counts, and bacterial iden-
tification were performed. Bacterial colonies were identified using standard biochemical
methods and confirmed using the Analytical Profile Index system (bioMérieux, Marcy-
l’Étoile, France) and antimicrobial susceptibility was determined using Kirby-Bauer disk
diffusion. Antibiotic breakpoints were defined using European Committee on Antimicro-
bial Susceptibility Testing (EUCAST) guidelines, version 5.0.[11] Enterobacteriaceae testing
intermediate or resistant to 3rd or 4th generation cephalosporins were evaluated for exten-
ded-spectrum β-lactamase (ESBL) production and considered ESBL phenotype if synergy
was observed between amoxicillin/clavulanic acid and ceftazidime or cefotaxime. ESBL test-
ing was not performed for non-lactose-fermenting Gram-negative rods.
Antimicrobial-resistant postpartum infections—Uganda
PLOS ONE | https://doi.org/10.1371/journal.pone.0175456 April 13, 2017 3 / 13
Participant demographic, medical, treatment, and outcomes data
Febrile or hypothermic participants and a random selection of normothermic participants
underwent additional in-depth data collection including interview and chart review. We ran-
domly selected 1,581 normothermic participants as a comparison group to achieve at least a
4:1 ratio of normothermic:febrile/hypothermic participants, maximizing power to detect dif-
ferences between groups. Demographic characteristics and health conditions were obtained
using a structured face-to-face interview in English or Runyankole created by study investiga-
tors. Medical charts were reviewed at hospital discharge to determine outcomes, diagnoses
and treatments received. Though antibiotic prescription is well-documented in charts, antibi-
otic administration is rarely recorded.
Defining infectious outcomes
Febrile and hypothermic participants were evaluated at the time of abnormal temperature
using structured physical exam and symptom questionnaire developed by study investigators
and administered by trained study nurses. Postpartum endometritis (puerperal sepsis) was
defined using the WHO technical working group 1992 definition as infection of the genital
tract in which two or more of the following were present: pelvic pain, fever>38.0˚C, abnormal
vaginal discharge, and delay in the rate of reduction of the size of the uterus<2cm/day.[12]
Uncomplicated UTI was defined by urinalysis positive for leukocyte esterase or nitrite and
urine culture growing105 colony-forming units (CFU) per milliliter (mL) of one or two
pathogens in the absence of nausea, vomiting, urinary catheterization, or flank pain.[13] Pyelo-
nephritis was defined by urine culture growing103 CFU/mL of one or two pathogens in the
presence of nausea, vomiting or flank pain.[13] Catheter-associated urinary tract infection
(CAUTI) was defined by urine culture growing103 CFU/mL of one or two pathogens with a
urinary catheter in place or removed within the previous 48 hours.[14] Bloodstream infection
(bacteremia) was defined as the growth of a potential pathogen in one or more blood culture
bottles. Diagnosis of superficial cesarean surgical site infection of the abdominal wall or skin
was abstracted from chart review. Our primary study outcome was confirmed postpartum
infection, a composite outcome including bloodstream infection, urinary tract infection, or
clinical endometritis diagnosed by our research staff using the definitions above. Cesarean sur-
gical site infection was not confirmed by research staff and not included in the composite pri-
mary outcome.
Data entry and statistical analysis
Questionnaires and laboratory results were entered into a Research Electronic Data Capture
(REDCap) database.[15] Demographic characteristics and outcomes were compared between
febrile/hypothermic participants and normothermic participants using Chi2 analysis. Addi-
tional analyses compared febrile/hypothermic women with a laboratory or clinically-confirmed
source of infection to those without a confirmed source. P-values<0.05 were considered statisti-
cally significant. All analyses were performed using Stata software (Version 12.0, StataCorp,
College Station, TX).
Ethics
All enrolled women provided written informed consent prior to data collection. Participants
<18 years of age were enrolled as emancipated minors based on pregnancy status. The study
and enrollment procedures were approved by the institutional ethics review boards at Mbarara
Antimicrobial-resistant postpartum infections—Uganda
PLOS ONE | https://doi.org/10.1371/journal.pone.0175456 April 13, 2017 4 / 13
University of Science and Technology (08/10-14), Partners Healthcare (2014P002725/MGH)
and the Uganda National Council of Science and Technology (HS/1729).
Results
Enrollment and demographics
Of all eligible women presenting to MRRH for care during the study period, over 99% (4,235)
were enrolled, and four withdrew before data collection was performed. Of the normothermic
cohort, 1,786 women were randomly selected for additional in-depth data collection. Mean
cohort age was 25.2 years (standard deviation (SD) 5.5 years), 667 (38%) were primiparous,
875 (50%) delivered by cesarean, and 212 (12%) were HIV-1 infected (Table 1). Overall, 1,567
(92%) had both chart review and interview data, and 1586 with either chart review or interview
data were included in the analysis (Fig 1).
Evaluation of fever and hypothermia
At least one temperature measurement was recorded for 4,176 (99%) of participants, and
two or more measurements were recorded for 2917 (69%). Of 205 (5%) febrile or hypothermic
participants, 174 (85%) completed physical exam and symptom questionnaire, blood and
urine cultures, and malaria RDT. Seven of 205 (3%) withdrew from the study, and seven (3%)
refused sample collection and clinical evaluation but did not withdraw. Another 17 underwent
partial microbiological evaluation: 11 (5%) were missing urine culture, one (0.5%) was missing
blood culture, three (1%) refused sample collection but underwent clinical examination, and
two (1%) refused clinical examination and sample collection but completed the symptom
questionnaire (Fig 1). The mean number of days between delivery and fever onset was 2.6 (SD
3.8).
In-hospital postpartum infection incidence
Overall, 84/174 (48%) febrile or hypothermic participants who underwent full clinical and
microbiological evaluation met criteria for one or more postpartum infections. Postpartum
endometritis was the most common source, identified in 76/193 (39%) who underwent clinical
evaluation, including 19 women evaluated clinically but who refused microbiologic evaluation.
Of 76 women with clinical endometritis, 61 (82%) delivered by cesarean, 7% of 875 cesarean
deliveries. Twenty-five of 175 (14%) participants with urinalysis and urine culture results met
criteria for UTI. Bloodstream infection was diagnosed in 5/185 (3%) participants with blood
cultures. Another 5/186 (3%) were malaria RDT-positive. Chart diagnosis of cesarean surgical
site infection was recorded for 5/205 (2%) febrile or hypothermic participants. The remaining
90/174 (52%) participants did not have a documented source of fever after our evaluation.
Urinary tract infections
Of 25 UTIs, one (4%) was uncomplicated, five (20%) were non-catheter-associated pyelone-
phritis, and 19 (76%) were catheter-associated UTIs (CAUTIs), including 5/19 (26%) cases of
pyelonephritis and 14/19 (74%) lower-tract UTIs (Table 2). Of all CAUTIs 17/19 (90%)
occurred in cesarean-delivery participants. Mean catheter days among CAUTI participants
was 1.9 (SD 0.6), which did not differ from non-CAUTI catheterized participants (2.4, SD 1.4,
P = 0.14). A single pathogen was recovered from 23/25 (92%) UTIs, while two pathogens were
recovered in 2/25 (8%). Six (24%) UTIs were caused by Gram-positive organisms, and the
remaining 19/25 (76%) by Gram-negatives. Acinetobacter spp. were the most common organ-
isms associated with UTIs (11/25, 44%), followed by Escherichia coli (5/25, 20%). Nine of 11
Antimicrobial-resistant postpartum infections—Uganda
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(82%) Enterobacteriaceae causing UTIs tested positive for extended-spectrum β-lactamase
(ESBL) production. Eighteen of 22 Gram-negative rods (82%) were cefepime non-susceptible,
and 17/22 (77%) were ciprofloxacin non-susceptible (Table 3). Of six UTIs identified by organ-
isms staining positive on Gram stain, 1/6 (17%) was caused by Candida spp., 3/6 (50%) by
coagulase-negative Staphylococcus spp., and 1/6 each (17%) by Enterococcus faecalis and
Enterococcus faecium (Tables 2 and 4).
Table 1. Demographic characteristics of a cohort of women presenting to a Ugandan referral hospital for delivery or postpartum care, comparing
febrile or hypothermic women with microbiologically-confirmed infection to febrile or hypothermic women in whom no infectious source was
found.
Total No confirmed Confirmed
cohort infection infection
Characteristic (N = 1786) (n = 90) (n = 84) P-value*
Age (years, mean, SDa) 25.2 (5.5) 24.4 (5.3) 22.6 (4.9) 0.02
Age category 0.07
<18 41 (2) 2 (2) 4 (5)
18–24 849 (49) 46 (53) 57 (68)
25–34 724 (41) 34 (39) 22 (26)
>34 133 (8) 5 (6) 1 (1)
Married (n, %) 1642 (93) 79 (91) 77 (92) 0.84
Residence in Mbarara (n, %) 728 (43) 23 (30) 27 (34) 0.60
Antenatal attendance 4 times 1249 (71) 57 (66) 65 (77) 0.09
Formally employed outside the home 684 (39) 21 (24) 23 (27) 0.63
Primiparous 667 (38) 36 (41) 57 (68) 0.001
Single gestation 1706 (97) 85 (97) 79 (94) 0.43
>5 vaginal exams during labor 180 (11) 9 (11) 6 (8) 0.53
Delivery mode 0.20
Spontaneous vaginal 855 (49) 18 (21) 10 (12)
Breech or assisted vaginal 8 (0.5) 0 (0) 1 (1)
Cesarean 875 (50) 68 (79) 71 (86)
HIVb infected 212 (12) 8 (9) 12 (14) 0.27
CD4c category 0.75
< 250 64 (14) 0 (0) 2 (18)
250–349 58 (13) 1 (13) 2 (18)
350–500 108 (24) 2 (25) 2 (18)
> 500 213 (48) 5 (63) 5 (46)
Admitted in labor 1571 (90) 73 (85) 73 (89) 0.43
Days postpartum at admission (if not in labor; mean, SDa) 12.9 (19.2) 7 (5.7) 5 (4.6) 0.72
Received peri-Cesarean antibiotic prophylaxis 802 (92) 59 (98) 63 (100) 0.20
Urinary catheter placement 918 (52) 69 (79) 75 (89) 0.07
Urinary catheter duration (days, mean, SDa) 2.0 (1.1) 2.2 (1.2) 2.4 (1.5) 0.36
Table 1 footnote
aSD: standard deviation
bHIV: human immunodeficiency virus
cCD4: CD4+ T-cell count.
*P-values were obtained using Chi squared statistic, or t-test for continuous normal variables, comparing febrile/hypothermic with a confirmed infection
source to those in whom no source was found.
https://doi.org/10.1371/journal.pone.0175456.t001
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Bloodstream infections
Bloodstream infection was diagnosed in five participants, 4/5 (60%) were Gram-negative (S.
typhi, Acinetobacter, probable Veillonella spp. and E. coli). Two of three (67%) Gram-negative
organisms tested for antimicrobial susceptibility were cefepime non-susceptible. One (20%)
bloodstream infection was caused by methicillin-sensitive Staphylococcus aureus (Tables 2, 3
and 4). No blood cultures were positive for mycobacteria.
Concomitant infections
Of 174 participants with a complete evaluation, 12/174 (7%) met criteria for both postpartum
endometritis and UTI, 3/174 (2%) for postpartum endometritis and bloodstream infection,
and none for bloodstream infection and UTI. Of five participants with positive malaria rapid
diagnostic tests, 1/5 (20%) met criteria for UTI, 1/5 (20%) for bloodstream infection, and 2/5
(40%) for endometritis. Three of five (60%) participants with a chart diagnosis of cesarean sur-
gical site infection also met criteria for postpartum endometritis.
Antibiotic prescription and in-hospital mortality
Of 875 cesarean delivery participants who underwent chart review, 788 (90%) were prescribed
combination intravenous ceftriaxone and metronidazole postpartum, though there was little
documentation of antibiotic receipt. Intravenous ceftriaxone and metronidazole was also pre-
scribed for 70/84 (83%) participants meeting criteria for one or more postpartum infections.
Another 11/84 (13%) had no antibiotic prescription, and 3/84 (4%) were prescribed alternative
antibiotic regimens. Two of 19 (11%) participants with Gram-negative UTIs, 0/5 (0%) with
Gram-positive bacterial UTIs and 2/5 (40%) with bloodstream infections were prescribed an
antibiotic to which the bacterium was susceptible. Overall, 802/875 (92%) women delivering
by cesarean had a chart-documented prescription for β-lactam perisurgical antibiotic
Fig 1. Enrollment flowchart demonstrating participants enrolled, retained and evaluated at each
stage as well as confirmed infectious diagnoses.
https://doi.org/10.1371/journal.pone.0175456.g001
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prophylaxis, including 63/71 (89%) of participants with postpartum infection. Antibiotic use
in the last year was reported by 149/1,748 women (9%) including 6/82 (7%) with confirmed
infection. Report of pre-hospital antibiotic receipt did not differ between febrile/hypothermic
participants with 6/82 (7%) or without 5/86 (6%) confirmed infection (P = 0.69). Three of 25
participants with UTI (12%) reported antibiotic use within the last year, and of these, urine
culture grew Enterococcus faecalis in one, yeast cells in the second, and the 3rd grew both
multi-drug resistant Klebsiella pneumoniae and Acinetobacter spp. In-hospital cumulative inci-
dence of postpartum infection did not differ by delivery mode (P = 0.20) or HIV status (P =
0.27). There were two in-hospital maternal deaths, neither of which were due to infection.
Discussion
Postpartum infection among rural Ugandan women hospitalized for delivery or postpartum
care was most commonly associated with antimicrobial-resistant Gram-negative rods. In-
Table 2. Postpartum infections listed by source of culture-positive sample, including pathogens
isolated.
URINARY TRACT INFECTIONS (N = 25)
Catheter-associated Non-catheter-associated
(n = 19, 76% of all UTIsa) (n = 6, 24% of all UTIsa)
Lower-tract (N = 14, 74%) Lower tract (N = 1, 17%)
Gram-negative (N = 9) Gram-negative (n = 1)
Acinetobacter spp. (n = 5) Klebsiella pneumonia and
Escherichia coli (n = 3) Acinetobacter spp. (n = 1)
Klebsiella pneumonia (n = 1)
Gram-positive (N = 5)
Coagulase-negative Staphylococcus (n = 2)
Enterococcus faecalis (n = 1)
Enterococcus faecium (n = 1)
Yeast, probable Candida spp. (n = 1)
Pyelonephritis (N = 5, 26%) Pyelonephritis (N = 5, 83%)
Gram-negative (n = 5) Gram-negative (N = 4)
Acinetobacter spp. (n = 3) Escherichia coli (n = 1)
Escherichia coli (n = 1) Escherichia coli and Acinetobacter spp. (n = 1)
Acinetobacter spp. and Klebsiella pneumoniae (n = 1)
Pseudomonas aeruginosa (n = 1) Bulkholderia cepacia (n = 1)
Gram-positive (N = 1)
Coagulase-negative Staphylococcus (n = 1)
BLOODSTREAM INFECTIONS (N = 5)
Gram-negative (N = 4, 80% of all BSIsb) Gram-positive (N = 1, 20% of all BSIsb)
Salmonella typhi (n = 1) Staphylococcus aureus (n = 1)
Probable Veillonella spp. (n = 1)
Escherichia coli (n = 1)
Acinetobacter junii (n = 1)
Table 2 footnote
aUTIs: urinary tract infections
bBSIs: bloodstream infections.
https://doi.org/10.1371/journal.pone.0175456.t002
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hospital incidence of endometritis, UTI, or bloodstream infection was 2%, and one or more
infections were found in 48% of febrile or hypothermic participants. Of 25 Gram-negative bac-
teria associated with UTI or bloodstream infection, 20 (80%) were multidrug-resistant and
cefepime non-susceptible. In this population of postpartum women, Acinetobacter spp. were
isolated more commonly than any other bacterium. Though Acinetobacter are not common
Table 3. Antimicrobial resistance in Gram-negative pathogens isolated from postpartum urine and blood culture samples, listed as number and
percentage testing non-susceptible (intermediate or resistant) to each antibiotic.
Ampi- Ceftriax- Genta- Tobra- Aztre- TMP/ Cipro- Erta-
cillin one Cefepime mycin mycin Amikacin onam SMXa floxacin penem ESBLb
Infection type (n, %) (n, %) (n, %) (n, %) (n, %) (n, %) (n, %) (n, %) (n, %) (n, %) (n, %)
Genus and species
URINARY TRACT (n = 22)
Acinetobacter spp. (n = 11) - - 11 (100) 11 (100) 10 (91) 1 (9) 11 (100) - 10 (91) - -
Escherichia coli (n = 6) 6 (100) 4 (67) 4 (67) 4 (67) 3 (50) 1 (17) 4 (67) 6 (100) 3 (50) 1 (17) 4 (67)
Klebsiella pneumoniae (n = 3) 3 (100) 3 (100) 3 (100) 2 (67) 2 (67) 0 (0) 3 (100) 3 (100) 3 (100) 0 (0) 3 (100)
Pseudomonas aeruginosa (n = 1) - - 0 (0) 1 (100) 1 (100) 0 (0) 1 (100) - 1 (100) - -
Bulkholderia cepacia (n = 1) - - 0 (0) 0 (0) 0 (0) 0 (0) 1 (100) - 0 (0) - -
BLOODSTREAM (n = 4)
Acinetobacter junii (n = 1) - - 1 (100) 1 (100) 1 (100) 0 (0) 1 (100) - 1 (100) - -
Salmonella typhi (n = 1) 1 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (100) 0 (0) 0 (0) -
Probable Veillonella spp. (n = 1) - - - - - - - - - - -
Escherichia coli (n = 1) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 0 (0) 1 (100) 1 (100) 1 (100) 0 (0) 1 (100)
Table 3 footnote:
aTMP/SMX: trimethoprim-sulfamethoxazole
bESBL: extended-spectrum β-lactamase.
https://doi.org/10.1371/journal.pone.0175456.t003
Table 4. Antimicrobial resistance in Gram-positive pathogens isolated from postpartum urine and blood culture samples, listed as number and
percentage testing non-susceptible (intermediate or resistant) to each antibiotic.
Peni- Ampi- Chloram- Cefox- Clinda- Erythro- Genta- TMP/ Nor- Tetra- Vanco- PCN-aseb
cillin cillin phenicol itin mycin mycin mycin SMXa floxacin cycline mycin positive
Infection type (n, %) (n, %) (n, %) (n, %) (n, %) (n, %) (n, %) (n, %) (n, %) (n, %) (n, %) (n, %)
Genus and species
URINARY TRACT (n = 5)
Coagulase-negative 3 (100) - 1 (33) 1 (33) 0 (0) 0 (0) 1 (0) 3 (100) 1 (0) - - 2 (66%)
Staphylococcus (n = 3)
Enterococcus faecalis (n = 1) - 1 (100) - - - - 1 (100) - 1 (100) - 0 (0) -
Enterococcus faecium (n = 1) - 1 (100) - - - - 1 (100) - 1 (100) - 0 (0) -
BLOODSTREAM (n = 1)
Staphylococcus aureus (n = 1) 0 (0) - 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) - - -
Table 4 footnote
aTMP/SMX: trimethoprim-sulfamethoxazole
bPCN-ase: penicillinase.
https://doi.org/10.1371/journal.pone.0175456.t004
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causes of urinary tract and bloodstream infection in young, healthy populations, mounting
evidence demonstrates the emergence of this pathogen as a cause of hospital-associated and
occasionally community-acquired infection in resource-limited settings.[5, 16–20] Receipt of
3rd generation cephalosporins (including ceftriaxone) is a known risk factor for Acinetobacter
baumanii infection or colonization, and 12/12 (100%) of the participants in whom Acinetobac-
ter spp. were isolated in urine or blood cultures were prescribed ceftriaxone. Klebsiella pneu-
monia and Escherichia coli, more common causes of UTIs in pregnancy and the postpartum
period,[21] also demonstrated high-level antibiotic resistance, with 8/10 (80%) resistant to 3rd
and 4th generation cephalosporins. Though some Gram-negative bacterial isolates could be
considered contaminants or colonizers, in our cohort samples came from participants with
clinical infection and urinalysis findings consistent with UTI, suggesting organisms isolated
are true pathogens. The high proportion of antimicrobial-resistant bacteria we report here is
concerning, considering only 4/29 (14%) participants were prescribed antibiotics to which
their bacterial isolate was susceptible.
Though infection incidence was overall low (2%), we report concerning findings of signifi-
cant antimicrobial resistance among nosocomial UTIs, which are understudied and likely
underestimated in resource-limited settings.[5, 22] The puerperium is especially high-risk for
UTI due to physiologic and hormonal changes inhibiting lower urinary tract defenses against
invading bacteria.[23] Urethral catheterization is common for cesarean deliveries, and incurs a
3–8% daily risk of bacteriuria, markedly enhancing risk of UTI.[14, 24] In our cohort, urine
catheter placement was documented in 96% of cesarean deliveries, for an average of 2 (SD 1)
days. Though UTI microbiology and antimicrobial resistance in sub-Saharan Africa is not well
described,[4, 5, 25] the high proportion of cephalosporin-resistant Gram-negative bacilli iso-
lated here is concerning for a growing epidemic of antibiotic resistance. Restricting use of uri-
nary catheters to patients with clear indications and removing catheters as early as possible
[14] may reduce the incidence of UTIs and limit spread of resistant organisms.
Peri-cesarean antibiotic prophylaxis (a single dose of β-lactam antibiotic) prior to cesarean
delivery reduces the incidence of postpartum endometritis threefold.[26, 27] Prophylactic anti-
biotic prescription was near-universal in our cohort, including those diagnosed with postpar-
tum infection, though most microbiologically-confirmed infections were resistant to common
prophylactic regimes. Additional treatment-dose intravenous ceftriaxone and metronidazole
was also prescribed to 80–90% of all women delivering by cesarean, though antibiotic receipt was
not well-documented. This local practice of administering three days’ intravenous antibiotics fol-
lowed by five days’ oral antibiotics post-cesarean has arisen from low maternity ward nurse-to-
patient staffing ratios (between 1:25 and 1:50) leading to concerns of less timely identification of
infections. In addition, lack of reliable microbiology testing makes infection recognition, diagno-
sis, and appropriate antimicrobial treatment impractical or impossible. Peri-cesarean antibiotic
prophylaxis guidelines recommend avoiding therapeutic multi-drug antibiotic regimens, limiting
prophylaxis to the simplest and shortest regimens possible to minimize selection pressure for
antibiotic-resistant organisms.[27] Antibiotic overuse for obstetric conditions and procedures is
common in clinical practice worldwide,[27] and in resource-limited settings such as MRRH, cli-
nicians may not always adhere to these guidelines, rationalizing treatment as prevention. Such
use of β-lactam antibiotic treatment regimens at MRRH as presumptive treatment may partially
explain high levels of antibiotic resistance and unusual organisms associated with infection in our
cohort, and is not unique to this setting[28].
Strengths of our study include the prospective cohort design, capturing nearly all women
presenting to MRRH for delivery or postpartum care within the study period, and near-com-
plete microbiologic evaluation of febrile and hypothermic women using a reliable microbiol-
ogy laboratory. One potential weakness is lack of genital tract cultures, which we chose not to
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collect, as culture results may not reflect the true pathogens causing endometritis.[10] How-
ever, our report of high levels of β-lactam antibiotic resistance in UTIs and bloodstream infec-
tions may inform endometritis treatment, which can involve similar pathogens. Our study is
also limited by lack of post-discharge fever evaluation. Patients delivering vaginally are often
discharged earlier than cesarean deliveries, and our results may reflect early-discharge bias
with fewer temperature measurements in vaginal delivery patients and shorter follow-up
resulting from shorter hospital stays. Some vaginal-delivery patients may have left the hospital
prior to enrollment or temperature measurement, inflating the proportion of cesarean deliver-
ies in our sample. In addition, though no in-hospital infection-related deaths occurred, we
were unable to follow participants post-discharge to determine infection outcomes, which
would be especially important for infections treated with ineffective antibiotic regimens.
Lastly, we did not investigate other causes of postpartum fever in our population. We did not
clinically confirm cesarean surgical site wound infection; diagnose dehydration, thrombophle-
bitis, pneumonia, or viral infection due to resource constraints, which may partially explain
why no source of fever was found in 52% of febrile or hypothermic women.[21]
Guidelines encourage consideration of local bacterial resistance when prescribing antibiot-
ics for postpartum infection treatment and prophylaxis,[29, 30] and we expect our findings
of highly prevalent β-lactam resistance among postpartum Gram-negative rod infections to
alter local practice. Improving adherence to antibiotic prophylaxis and treatment guidelines,
expanding antimicrobial stewardship programs and infection control, and increasing the avail-
ability of microbiology testing to inform appropriate antibiotic use should become high priori-
ties in Uganda and similar resource-limited settings.[31] Further research should address when
and where antibiotic-resistant bacteria are acquired, infection outcomes, and local challenges in
guideline implementation.
In conclusion, we demonstrate that infection microbiology among febrile and hypothermic
Ugandan women hospitalized for delivery or postpartum care is dominated by antibiotic-resis-
tant Gram-negative rods. Increasing availability of microbiology testing to inform appropriate
antibiotic use, strengthening antimicrobial stewardship programs, and improving adherence
to guidelines should be high priorities.
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